THE MCMANUS GROUP for NOVARTIS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Pharmaceutical coverage and access in Parts A, B, C, and D.
Foreign entity interest: Novartis AG, Fabrikstrasse 2, 4056 Basel, Switzerland
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Taxation/Internal Revenue Code TAX
Legislation and regulations affecting taxation of pharmaceutical products, including research and development and orphan drug tax credits. Protecting Americans From Tax Hikes Act of 2015.
Foreign entity interest: Novartis AG, Fabrikstrasse 2, 4056 Basel, Switzerland
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Health Issues HCR
Education and advocacy regarding novel biopharmaceutical products. H.R.6 - 21st Century Cures Act.Advocacy and policy development regarding 340B.
Foreign entity interest: Novartis AG, Fabrikstrasse 2, 4056 Basel, Switzerland
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.